STOCK TITAN

Cognyte Software (CGNT) Financials

CGNT
FY2025 annual
Revenue $400.0M +14.1% YoY
Net Income -$638K +94.7% YoY
EPS (Diluted) -$0.01 +94.1% YoY
Free Cash Flow $29.9M -17.3% YoY
Market Cap $592.2M as of Sep 11, 2026
Price / Sales 1.5x on $400.0M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 2.9x on $206.5M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Jan 31, 2026 Reported Currency USD FYE January

Newest figures come from the 20-F for FY2025, filed Mar 25, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CGNT SEC filings page.

Cognyte Software (CGNT) reported $400.0M in revenue for fiscal year 2025, up 14.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CGNT FY2025

Cognyte’s dominant shift is from deep operating losses to modest profitability, while cash generation outruns reported earnings.

Cognyte moved from operating cash flow of -$37.0M in FY2022 to $40.3M in FY2025, even as net income remained a -$638K loss. With free cash flow at $29.9M, the latest cash result reflects working-capital and operating improvements rather than accounting profit alone.

Gross-margin expansion from 61.6% in FY2022 to 72.4% in FY2025 increased the dollars available to fund overhead. Operating margin then moved from -33.1% to 3.3% as revenue recovered, indicating better cost absorption, although the data do not isolate mix from cost discipline.

Liabilities reached $292M against $207M of equity in FY2025, leaving the business financed more heavily by obligations than book capital. A 1.4x debt-to-equity ratio alongside a 1.3x current ratio makes leverage and short-term coverage important parts of the operating picture.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 52 / 100
Financial Health Score 52/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cognyte Software's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
85

Cognyte Software held $116.9M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $40.3M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Cognyte Software scores 85/100 among other emerging companies.

Dilution
67

Cognyte Software had 73M shares outstanding at the end of fiscal year 2025, against 72M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Cognyte Software scores 67/100 among other emerging companies.

R&D Intensity
63

Cognyte Software spent $122.3M on research and development in fiscal year 2025, which was 31.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Cognyte Software scores 63/100 among other emerging companies.

Revenue Progress
59

Cognyte Software reported revenue of $400.0M in fiscal year 2025, against $350.6M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Cognyte Software scores 59/100 among other emerging companies.

Burn Trend
0

Not available for Cognyte Software, and counted as zero in the overall score.

Balance Sheet
39

Cognyte Software's cash, cash equivalents and investments came to $116.9M at the end of fiscal year 2025, against $292.2M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Cognyte Software scores 39/100 among other emerging companies.

Altman Z-Score Grey Zone
1.82

Cognyte Software scores 1.82, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($592.2M) relative to total liabilities ($292.2M). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Cognyte Software passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Cognyte Software reported a net loss of $638K while generating $40.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2026.

Cash & Balance Sheet

Cash & Debt
$116.9M
YoY+3.7%
QoQ+3.7%

Cognyte Software held $116.9M in cash as of Q4 2026; long-term debt is not reported for that period.

Shares Outstanding
73M
YoY+1.4%
QoQ+1.4%

Cognyte Software had 73M shares outstanding in Q4 2026. This represents an increase of 1.4% from the same quarter a year earlier. Against the prior quarter it is up 1.4%.

Free Cash Flow

Not reported for Q4 2026.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

None of these metrics is reported for Q4 2026.

Capital Allocation

None of these metrics is reported for Q4 2026.

CGNT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CGNT quarterly income statement
MetricQ4'2620-FQ4'2520-FQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CGNT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CGNT quarterly balance sheet
MetricQ4'2620-FQ4'2520-FQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K
Total Assets$521.1M+4.7%$497.8M+5.5%$472.1M+6.5%$443.1M-33.3%$664.6M+5.7%$628.8M-21.9%$805.1M
Current Assets$298.3M+4.2%$286.2M+8.0%$265.0M+5.3%$251.7M-40.1%$420.1M+19.9%$350.2M-31.6%$512.2M
Cash & Equivalents$116.9M+3.7%$112.7M+51.3%$74.5M+115.4%$34.6M-77.3%$152.6M+94.2%$78.6M-60.9%$201.1M
Short-Term Investments$0$0$0-100.0%$17.5M+67.8%$10.4M+121.4%$4.7M-28.6%$6.6M
Inventory$16.4M-13.6%$19.0M-22.8%$24.6M-2.7%$25.3M+75.9%$14.4M-1.2%$14.5M-2.4%$14.9M
Accounts Receivable$122.5M+12.0%$109.4M-3.4%$113.3M+0.1%$113.2M-36.8%$179.2M+2.4%$175.0M-3.0%$180.4M
Long-Term Investments$0$0$0$0$0$0$0
Goodwill$126.6M+0.4%$126.1M-0.3%$126.6M+0.1%$126.5M-20.1%$158.2M0.0%$158.2M0.0%$158.1M
Total Liabilities$292.2M+4.1%$280.7M+9.1%$257.3M+10.3%$233.3M-36.2%$365.5M+2.0%$358.4M+2.4%$349.9M
Current Liabilities$224.0M+2.1%$219.4M+15.2%$190.5M-1.7%$193.9M-39.3%$319.6M+6.9%$299.0M+6.8%$280.1M
Non-Current Liabilities$68.2M+11.1%$61.4M-8.3%$66.9M+69.5%$39.4M-14.1%$45.9M-22.7%$59.4M-15.0%$69.9M
Total Equity$206.5M+4.2%$198.2M+0.2%$197.9M+1.9%$194.1M-31.9%$285.1M+10.7%$257.5M-42.1%$444.5M
Retained Earnings-$157.3M-0.4%-$156.6M-8.3%-$144.6M-12.1%-$129.0M-766.5%-$14.9M$0N/A

Not reported in any period shown, so not listed: Long-Term Debt.

CGNT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CGNT quarterly cash flow statement
MetricQ4'2620-FQ4'2520-FQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

CGNT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CGNT quarterly financial ratios
MetricQ4'2620-FQ4'2520-FQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-KQ4'2010-K
Current Ratio1.330.0x1.30-0.1x1.39+0.1x1.300.0x1.31+0.1x1.17-0.7x1.83
Debt-to-Equity1.410.0x1.42+0.1x1.30+0.1x1.20-0.1x1.28-0.1x1.39+0.6x0.79

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Cognyte Software CGNT FY2025 $400.0M -$638K -0.2% $592.2M 52/100
Sabre Corp SABR FY2025 $2.8B $524.6M 18.9% $863.7M 29/100
Priority Technology Hldgs Inc PRTH FY2025 $953.0M $55.7M 5.8% $475.3M 51/100
Onespan Inc OSPN FY2025 $243.2M $72.9M 30.0% $607.7M 53/100
Powerfleet, Inc. AIOT FY2026 $443.8M $20.6M 4.6% $396.0M 39/100
CI&T Inc CINT FY2025 $489.6M $40.6M 8.3% $390.4M 28/100

Frequently Asked Questions

What is Cognyte Software's annual revenue?

Cognyte Software (CGNT) reported $400.0M in total revenue for fiscal year 2025. This represents a 14.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cognyte Software's revenue growing?

Cognyte Software (CGNT) revenue grew by 14.1% year-over-year, from $350.6M to $400.0M in fiscal year 2025.

Is Cognyte Software profitable?

No, Cognyte Software (CGNT) reported a net income of -$638K in fiscal year 2025, with a net profit margin of -0.2%.

Cognyte Software (CGNT) reported diluted earnings per share of -$0.01 for fiscal year 2025. This represents a 94.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cognyte Software (CGNT) had EBITDA of $25.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Cognyte Software (CGNT) had a gross margin of 72.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Cognyte Software (CGNT) had an operating margin of 3.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Cognyte Software (CGNT) had a net profit margin of -0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Cognyte Software (CGNT) has a return on equity of -0.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Cognyte Software (CGNT) generated $29.9M in free cash flow during fiscal year 2025. This represents a -17.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Cognyte Software (CGNT) generated $40.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Cognyte Software (CGNT) had $521.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Cognyte Software (CGNT) invested $10.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Cognyte Software (CGNT) invested $122.3M in research and development during fiscal year 2025.

Cognyte Software (CGNT) had 73M shares outstanding as of fiscal year 2025.

Cognyte Software (CGNT) had a current ratio of 1.33 as of fiscal year 2025, which is considered adequate.

Cognyte Software (CGNT) had a debt-to-equity ratio of 1.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cognyte Software (CGNT) had a return on assets of -0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Cognyte Software (CGNT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $592.2M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cognyte Software (CGNT) trades at 1.5x sales, its market capitalization divided by revenue of $400.0M revenue, FY2025. The market capitalization is $592.2M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cognyte Software (CGNT) has an Altman Z-Score of 1.82, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Cognyte Software (CGNT) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cognyte Software (CGNT) reported a net loss of $638K while generating $40.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cognyte Software (CGNT) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top